Cargando…

Trabeculotomy in a Behçet's Disease Patient One Week after Infliximab Administration

PURPOSE: To describe a patient with Behçet's disease and anterior uveitis, which was not cured by local and systemic corticosteroid treatments, who underwent trabeculotomy one week after infliximab administration. METHODS: The patient received preoperative antibiotic therapy followed by trabecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Koike, Aya, Handa, Tsuneaki, Zako, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369265/
https://www.ncbi.nlm.nih.gov/pubmed/22701422
http://dx.doi.org/10.1159/000338703
Descripción
Sumario:PURPOSE: To describe a patient with Behçet's disease and anterior uveitis, which was not cured by local and systemic corticosteroid treatments, who underwent trabeculotomy one week after infliximab administration. METHODS: The patient received preoperative antibiotic therapy followed by trabeculotomy one week after infliximab administration. We observed ocular findings before and after surgery. RESULTS: Anterior uveitis improved after infliximab administration. The elevated intraocular pressure improved after surgery and there were no intraoperative complications. Neither ocular inflammatory attacks nor infectious complications were found in the operated eye of the patient during follow-up. CONCLUSION: Trabeculotomy one week after administration of infliximab appears to be safe and effective in treating secondary glaucoma associated with Behçet's disease.